These relatively recent initiatives deserve recognition for helping the scientific community.
If universities are interested in incentivizing translational research, the economics for scientists needs to change.
Startup culture is blurring the lines between universities as knowledge creators and companies as knowledge translators.
Contrary to current thinking in Canadian circles, David Kent says it is absolutely essential to tie the program to funding.
Canada’s newest Nobel laureate discusses the challenges of explaining her work, dealing with the sudden attention, and what to say to the Queen of Sweden.
Pseudo-science “erodes our critical thinking, and that might be the most serious damage in the long run,” says one professor.
While anything can be funded, scientific research teams often need to demonstrate a realistic path to a financial return on investment to get funded.
The current academic career structure rewards short-term deliverables rather than high-risk, high-reward research.
How the Bayh-Dole Act succeeded in kickstarting an explosion of technological innovation.
The culture of scientific research desperately needs a makeover. Enter the eLife Ambassador program.
Translational research should be scientist-driven and institutionally supported, not the other way around.
While every organization is different, sharing best practices can help inform process development.
It is sad that highly-qualified, highly-educated scientific researchers need to worry about pleading their case to have a national pension contribution.
The scientific profession is not for everyone, but there is no reason why we should actively be forcing people out.
Whatever we call it, investment in research will lead the way to important short- and long-term discoveries.
While no one is arguing for funding failure, the challenge is how we define “success.”
David Kent looks at whether it is ethical (and legal) for an academic to share a paper they are reviewing with their lab group.
Among the most interesting implications is the recognition that universities are not exempt from patent infringement for basic research.
I can happily report that something has indeed changed at NSERC and the number of postdoctoral fellowships being awarded is definitely recovering.
This U.S. act allows biotech startups to use patented technology for the purposes of generating data for FDA approval without needing to take out costly licenses.